Nature's Way

Garlicin CF

Serving

1 Tablet(s)

Per container

Form

tablet

UPC

033674067956

DSLD

273459

Formula hash

c616a0eee084

Brand context

Nature's Way

Catalog

3,433

products

With avoid flag

209

products

FDA recalls

history

CAERS

reports

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 0 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

5 active ingredients

Ingredient	Amount	% DV
Vitamin C vitaminUNII · PQ6CK8PD0R UL · set5 effects	20 mg	22%
L-OptiZinc Zincherb UL · set8 effects	5 mg	45%
Echinacea purpurea herbUNII · QI7G114Y98	205 mg	—
Garlic herbUNII · V1V998DC17	105 mg	—
Citrus Bioflavonoid Complex Flavonoid (mixture)herb	40 mg	—

What this product supports · authorized claims

11 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Collagen formation (for blood vessels, bone, skin)
from: Vitamin C
EFSAEU-Reg-432/2012-ID-130 →
↑Normal immune system function
from: Vitamin C · Zinc
EFSAEU-Reg-432/2012-ID-134 →
↑Iron absorption
from: Vitamin C
EFSAEU-Reg-432/2012-ID-132 →LOINC 2498-4
↑Normal cognitive function
from: Zinc
EFSAEU-Reg-432/2012-ID-296 →
↑Normal DNA synthesis
from: Zinc
EFSAEU-Reg-432/2012-ID-293 →
↑Maintenance of normal bones
from: Zinc
EFSAEU-Reg-432/2012-ID-295 →
↑Maintenance of normal vision (at 250 mg/day)
from: Zinc
EFSAEU-Reg-432/2012-ID-361 →
↑Maintenance of normal hair and skin
from: Zinc
EFSAEU-Reg-432/2012-ID-293 →
↑Maintenance of normal testosterone levels
from: Zinc
EFSAEU-Reg-432/2012-ID-359 →LOINC 2986-8
↓Protection from oxidative stress
from: Vitamin C · Zinc
EFSAEU-Reg-432/2012-ID-135 →
↓Reduction of tiredness and fatigue
from: Vitamin C
EFSAEU-Reg-432/2012-ID-139 →

Flagged excipients

1 flagged · authority citations

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Cellulose · Dicalcium Phosphate · Sodium Croscarmellose · Stearic Acid · Hypromellose · Sodium Alginate · Silica · Ethylcellulose · Glycerin · Medium Chain Triglycerides · Oleic Acid · Riboflavin